Margaret M Harnett, James Doonan, Anuradha Tarafdar, Miguel A Pineda, Josephine Duncombe-Moore, Geraldine Buitrago, Piaopiao Pan, Paul A Hoskisson, Colin Selman, William Harnett
{"title":"寄生蠕虫产品 ES-62 以微生物依赖的方式重置肠道-骨髓轴,从而预防胶原蛋白诱发的关节炎。","authors":"Margaret M Harnett, James Doonan, Anuradha Tarafdar, Miguel A Pineda, Josephine Duncombe-Moore, Geraldine Buitrago, Piaopiao Pan, Paul A Hoskisson, Colin Selman, William Harnett","doi":"10.3389/fitd.2023.1334705","DOIUrl":null,"url":null,"abstract":"<p><p>The parasitic worm-derived immunomodulator, ES-62 rescues defective levels of IL-10-producing regulatory B cells (Bregs) and suppresses chronic Th1/Th17-driven inflammation to protect against joint destruction in the mouse collagen-induced arthritis (CIA) model of rheumatoid arthritis. Such autoimmune arthritis is also associated with dysbiosis of the gut microbiota and disruption of intestinal barrier integrity. We recently further exploited the CIA model to show that ES-62's prevention of joint destruction is associated with protection of intestinal barrier integrity and normalization of the gut microbiota, thereby suppressing the gut pathology that precedes the onset of autoimmunity and joint damage in CIA-mice. As the status of the gut microbiota impacts on immune responses by influencing haematopoiesis, we have therefore investigated whether ES-62 harnesses the homeostatic mechanisms regulating this gut-bone marrow (BM) axis to resolve the chronic inflammation promoting autoimmunity and joint destruction in CIA. Reflecting this, ES-62 was found to counteract the BM myeloid/lymphoid bias typically associated with chronic inflammation and infection. This was achieved primarily by ES-62 acting to maintain the levels of lymphoid lineages (B220<sup>+</sup> and CD3<sup>+</sup> cells) observed in naïve, healthy mice but lost from the BM of CIA-mice. Moreover, ES-62's ability to prevent bone-destroying osteoclastogenesis was found to be associated with its suppression of CIA-induced upregulation of osteoclast progenitors (OCPs) in the BM. Critically, and supporting ES-62's targeting of the gut-BM axis, this rewiring of inflammatory haematopoiesis was lost in mice with a depleted microbiome. Underlining the importance of ES-62's actions in restoring steady-state haematopoiesis, the BM levels of B and T lymphoid cells were shown to be inversely correlated, whilst the levels of OCPs positively correlated, with the severity of joint damage in CIA-mice.</p>","PeriodicalId":73112,"journal":{"name":"Frontiers in tropical diseases","volume":"4 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615750/pdf/","citationCount":"0","resultStr":"{\"title\":\"The parasitic worm product ES-62 protects against collagen-induced arthritis by resetting the gut-bone marrow axis in a microbiome-dependent manner.\",\"authors\":\"Margaret M Harnett, James Doonan, Anuradha Tarafdar, Miguel A Pineda, Josephine Duncombe-Moore, Geraldine Buitrago, Piaopiao Pan, Paul A Hoskisson, Colin Selman, William Harnett\",\"doi\":\"10.3389/fitd.2023.1334705\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The parasitic worm-derived immunomodulator, ES-62 rescues defective levels of IL-10-producing regulatory B cells (Bregs) and suppresses chronic Th1/Th17-driven inflammation to protect against joint destruction in the mouse collagen-induced arthritis (CIA) model of rheumatoid arthritis. Such autoimmune arthritis is also associated with dysbiosis of the gut microbiota and disruption of intestinal barrier integrity. We recently further exploited the CIA model to show that ES-62's prevention of joint destruction is associated with protection of intestinal barrier integrity and normalization of the gut microbiota, thereby suppressing the gut pathology that precedes the onset of autoimmunity and joint damage in CIA-mice. As the status of the gut microbiota impacts on immune responses by influencing haematopoiesis, we have therefore investigated whether ES-62 harnesses the homeostatic mechanisms regulating this gut-bone marrow (BM) axis to resolve the chronic inflammation promoting autoimmunity and joint destruction in CIA. Reflecting this, ES-62 was found to counteract the BM myeloid/lymphoid bias typically associated with chronic inflammation and infection. This was achieved primarily by ES-62 acting to maintain the levels of lymphoid lineages (B220<sup>+</sup> and CD3<sup>+</sup> cells) observed in naïve, healthy mice but lost from the BM of CIA-mice. Moreover, ES-62's ability to prevent bone-destroying osteoclastogenesis was found to be associated with its suppression of CIA-induced upregulation of osteoclast progenitors (OCPs) in the BM. Critically, and supporting ES-62's targeting of the gut-BM axis, this rewiring of inflammatory haematopoiesis was lost in mice with a depleted microbiome. Underlining the importance of ES-62's actions in restoring steady-state haematopoiesis, the BM levels of B and T lymphoid cells were shown to be inversely correlated, whilst the levels of OCPs positively correlated, with the severity of joint damage in CIA-mice.</p>\",\"PeriodicalId\":73112,\"journal\":{\"name\":\"Frontiers in tropical diseases\",\"volume\":\"4 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615750/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in tropical diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/fitd.2023.1334705\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in tropical diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fitd.2023.1334705","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
寄生蠕虫衍生的免疫调节剂 ES-62 能挽救产生 IL-10 的调节性 B 细胞(Bregs)的缺陷水平,并抑制 Th1/Th17 驱动的慢性炎症,从而保护类风湿性关节炎的小鼠胶原诱导关节炎(CIA)模型免受关节破坏。这种自身免疫性关节炎还与肠道微生物群失调和肠道屏障完整性破坏有关。我们最近进一步利用 CIA 模型表明,ES-62 预防关节破坏与保护肠道屏障完整性和肠道微生物群正常化有关,从而抑制了 CIA 小鼠自身免疫和关节损伤发生前的肠道病变。由于肠道微生物群的状态会影响造血功能,从而影响免疫反应,因此我们研究了 ES-62 是否能利用调节肠道-骨髓(BM)轴的平衡机制来解决促进 CIA 自身免疫和关节破坏的慢性炎症。研究发现,ES-62 能够抵消骨髓中与慢性炎症和感染相关的骨髓/淋巴细胞偏向。这主要是通过 ES-62 的作用来实现的,ES-62 能够维持在健康小鼠中观察到的淋巴细胞系(B220+ 和 CD3+ 细胞)的水平,但这些淋巴细胞系在 CIA 小鼠的 BM 中却消失了。此外,研究还发现 ES-62 预防破坏骨的破骨细胞生成的能力与其抑制 CIA 诱导的破骨细胞祖细胞(OCPs)在 BM 中的上调有关。重要的是,ES-62以肠道-BM轴为靶点,这种炎症性造血的重构在微生物群被破坏的小鼠中消失了,这也支持了ES-62的靶向作用。ES-62在恢复稳态造血方面的作用强调了其重要性,研究表明,B淋巴细胞和T淋巴细胞的生化水平与CIA小鼠关节损伤的严重程度成反比,而OCPs的水平则成正比。
The parasitic worm product ES-62 protects against collagen-induced arthritis by resetting the gut-bone marrow axis in a microbiome-dependent manner.
The parasitic worm-derived immunomodulator, ES-62 rescues defective levels of IL-10-producing regulatory B cells (Bregs) and suppresses chronic Th1/Th17-driven inflammation to protect against joint destruction in the mouse collagen-induced arthritis (CIA) model of rheumatoid arthritis. Such autoimmune arthritis is also associated with dysbiosis of the gut microbiota and disruption of intestinal barrier integrity. We recently further exploited the CIA model to show that ES-62's prevention of joint destruction is associated with protection of intestinal barrier integrity and normalization of the gut microbiota, thereby suppressing the gut pathology that precedes the onset of autoimmunity and joint damage in CIA-mice. As the status of the gut microbiota impacts on immune responses by influencing haematopoiesis, we have therefore investigated whether ES-62 harnesses the homeostatic mechanisms regulating this gut-bone marrow (BM) axis to resolve the chronic inflammation promoting autoimmunity and joint destruction in CIA. Reflecting this, ES-62 was found to counteract the BM myeloid/lymphoid bias typically associated with chronic inflammation and infection. This was achieved primarily by ES-62 acting to maintain the levels of lymphoid lineages (B220+ and CD3+ cells) observed in naïve, healthy mice but lost from the BM of CIA-mice. Moreover, ES-62's ability to prevent bone-destroying osteoclastogenesis was found to be associated with its suppression of CIA-induced upregulation of osteoclast progenitors (OCPs) in the BM. Critically, and supporting ES-62's targeting of the gut-BM axis, this rewiring of inflammatory haematopoiesis was lost in mice with a depleted microbiome. Underlining the importance of ES-62's actions in restoring steady-state haematopoiesis, the BM levels of B and T lymphoid cells were shown to be inversely correlated, whilst the levels of OCPs positively correlated, with the severity of joint damage in CIA-mice.